GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Other Operating Expense

Divi's Laboratories (NSE:DIVISLAB) Other Operating Expense : ₹27,190 Mil (TTM As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Other Operating Expense?

Divi's Laboratories's Other Operating Expense for the three months ended in Mar. 2025 was ₹8,250 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₹27,190 Mil.

Divi's Laboratories's quarterly Other Operating Expense increased from Sep. 2024 (₹7,520 Mil) to Dec. 2024 (₹7,530 Mil) and increased from Dec. 2024 (₹7,530 Mil) to Mar. 2025 (₹8,250 Mil).

Divi's Laboratories's annual Other Operating Expense increased from Mar. 2023 (₹21,900 Mil) to Mar. 2024 (₹26,390 Mil) and increased from Mar. 2024 (₹26,390 Mil) to Mar. 2025 (₹30,690 Mil).


Divi's Laboratories Other Operating Expense Historical Data

The historical data trend for Divi's Laboratories's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Other Operating Expense Chart

Divi's Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,875.40 18,778.20 21,900.00 26,390.00 30,690.00

Divi's Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,630.00 3,890.00 7,520.00 7,530.00 8,250.00

Divi's Laboratories Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹27,190 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Divi's Laboratories Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Divi's Laboratories Business Description

Traded in Other Exchanges
Address
Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines